NASDAQ: AHCO

AdaptHealth Corp.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of AdaptHealth Corp. (NASDAQ: AHCO) between (1) August 4, 2020 and February 27, 2023, both dates inclusive (the “Class Period”) or (2) AdaptHealth common stock pursuant and/or traceable to the Company’s secondary public offering (the “SPO”) conducted on or around January 5, 2021. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 26, 2023.

If you purchased AdaptHealth common stock during the Class Period and would like to join the action, please click “Join This Class Action.”

Class Period:(1) between August 4, 2020 and February 27, 2023, both dates inclusive (the “Class Period”) or (2) AdaptHealth common stock pursuant and/or traceable to the Company’s January 5, 2021 secondary public offering (the “SPO”).
If you purchased AdaptHealth common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Details of the case:

According to the lawsuit, defendants made false and/or misleading statements because:

  • AdaptHealth misstated the Company’s true ability to generate organic growth in its diabetes segment;
  • AdaptHealth engaged in improper upcoding and other illicit billing practices;
  • that, as a result of the foregoing, certain of the defendants’ statements about the Company’s business, operations and prospects were materially misleading and/or lacked a reasonable basis.

Further, the lawsuit alleges the “SPO Offering Materials contained untrue statements of material fact, omitted material facts necessary to make the statements contained therein not misleading, and failed to make adequate disclosures required under the rules and regulations governing the preparation of such documents.” 

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Follow us on:
Company Name: AdaptHealth Corp.
Stock Symbol: AHCO
Class Period: between (1) August 4, 2020 and February 27, 2023, both dates inclusive (the “Class Period”) or (2) AdaptHealth common stock pursuant and/or traceable to the Company’s secondary public offering (the “SPO”) conducted on or around January 5, 2021.
Court: United States District Court for the Eastern District of Pennsylvania

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Scroll to Top